Clostridium botulinum

DB14223InvestigationalOrganism Based Therapies

Clostridium botulinum: Overview.

Mechanism: Pharmacologically active on Synaptosomal-associated protein 25
Curator reviewed
Also known as: Bacillus botulinus whole · Bacillus putrificus whole · Botulobacillus botulinus whole · Clostridium botulinum whole · Clostridium putrificum whole

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

9Structured indicationsCondition, population, route and combination as fields, not prose

50Marketed productsAcross 3 countries and 12 labellers

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Clostridium botulinum, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.